Asthma patients who rely on over-the-counter inhalers will need to switch to prescription-only alternatives as part of the federal government's latest attempt to protect the Earth's atmosphere ...

Selecting appropriate inhalers based on individual characteristics and shared decision-making is crucial for optimizing care for patients with COPD.

The question of whether rescue inhalers should be OTC is a difficult one, and I’m glad that we are having a discussion in the pulmonary and allergy communities about strengthening access to therapy.

Patients with COPD had better inhaler adherence when invited to enroll in a program that lowers cost sharing for maintenance inhalers and offers medication management services, according to ...

The first Symbicort generic, simply referred to as budesonide/formoterol inhaler, was approved by the Food and Drug Administration (FDA) in February 2020 and is roughly half the cost of Symbicort ...

For patients with asthma or chronic obstructive pulmonary disease (COPD) using an inhaler, switching their inhaler regimen with or without consent can lead to unpredictable, inconsistent results ...

Metered-dose inhaler budesonide-glycopyrrolate-formoterol (Breztri Aerosphere) was associated with a higher risk of a first moderate or severe COPD exacerbation (HR 1.09, 95% CI 1.04-1.14 ...

Geoffrey Clemence can't take breathing for granted. "I've had asthma for as long as I can remember," the 27-year-old Fountain City, Wis., resident said.

Electronic inhaler monitoring combined with a disease management program was associated with reduced hospitalizations in patients with chronic pulmonary disease (COPD), according to a new study ...

Medicare Part D and Medicare Advantage (Part C) plans with drug coverage typically cover inhalers for COPD. But you may still be responsible for a portion of the cost. If you have chronic ...

Smart inhaler company Adherium announced last week that it has received 510(k) clearance for over-the-counter sales of its inhaler monitoring device for AstraZeneca’s Symbicort aerosol inhaler, called ...

About 69% of hospitalized COPD patients misused inhalers, 66% made critical errors during inhaler use, and 14% had insufficient PIF. An average of 1.4 and 1.3 and critical errors for every inhaler ...